K.J. Harrison & Partners Inc Guardant Health, Inc. Transaction History

K.J. Harrison & Partners Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$20.94 - $38.01 $209,400 - $380,100	-10,000 Reduced 53.94%	8,540 $305,000
Q1 2023 Apr 24, 2023	BUY	$22.92 - $33.76 $424,936 - $625,910	18,540 New	18,540 $434,000
Q3 2022 Oct 21, 2022	SELL	$43.66 - $61.0 $305,620 - $427,000	-7,000 Reduced 50.4%	6,890 $371,000
Q4 2021 Jan 26, 2022	BUY	$88.71 - $120.43 $887,987 - $1.21 Million	10,010 Added 257.99%	13,890 $1.39 Million
Q2 2021 Aug 04, 2021	BUY	$109.77 - $165.68 $3,293 - $4,970	30 Added 0.78%	3,880 $482,000
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $2.54 Million - $3.58 Million	-20,000 Reduced 83.86%	3,850 $588,000
Q4 2020 Feb 08, 2021	BUY	$99.96 - $135.93 $2.38 Million - $3.24 Million	23,850 New	23,850 $3.07 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.